Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for bioAffinity Technologies, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
SM
Sabby Management, LLC
|
365.6K | 40.80% | NEW | Q2 '26 | 0.3% | |
|
Shares held by quarter
Peak holding365.6K (Q2'26)
Change over 8 quarters+365.6K
Share of the company40.800%
|
||||||
|
B
BlackRock, Inc.
|
98.8K | 11.02% | NEW | Q2 '26 | 0.0% | |
|
Shares held by quarter
Peak holding98.8K (Q2'26)
Change over 8 quarters+98.8K
Share of the company11.020%
|
||||||
22 more super investors behind a free account
See every manager holding bioAffinity Technologies, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FE
Fidelity Concord Street Trust
|
$46.9K | 28.1K | 3.13% | 0.00% | May 31, 2026 |
|
VE
Vanguard Index Funds
|
$45.1K | 55.5K | 6.20% | 0.00% | June 30, 2026 |
6 more funds behind a free account
See every fund holding bioAffinity Technologies, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
JR
Joyce Roby
Insider
|
649.7K | 72.49% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company72.490%
|
||||||
|
ZM
Zannes Maria
Insider
|
280.4K | 31.28% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company31.280%
|
||||||
10 more holders behind a free account
See every insider and 5%+ holder of bioAffinity Technologies, Inc..
Sign up freeLoading...